How to Manage Risk in Speculative Biotech Stocks By: TalkMarkets April 24, 2018 at 06:19 AM EDT Biotech IPOs are a special animal. Not only are the companies usually not profitable, but most of the time they don’t even have a product on the market yet. Read More >> Related Stocks: AbbVie Surface Oncology Inc